Premium
Secukinumab for the treatment of SAM syndrome associated with desmoglein‐1 deficiency
Author(s) -
Frommherz L.H.,
Schempp C.M.,
Has C.
Publication year - 2021
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.19684
Subject(s) - secukinumab , medicine , dermatology , desmoglein 1 , immunology , antibody , autoantibody , psoriasis , psoriatic arthritis
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom